Profile data is unavailable for this security.
About the company
Inspiration Healthcare Group plc is a United Kingdom-based provider of medical technology for use in neonatal intensive care and operating theatres. The Company provides products to patients around the world which help to improve patient outcomes, and it actively invests in product opportunities and disruptive technologies. Its areas of care include Acute Care and Infusion Therapies. Its Acute Care product include neonatal, operating theaters, respiratory, auto FiO2, obstetrics and developmental care. It offers a full range of ambulatory infusion pumps, administration sets, accessories, and patient infusion management systems for both hospital and homecare applications. It provides a range of Micrel Medical infusion devices, for various applications such as parenteral nutrition, oncology, immunoglobulin therapy, antibiotic infusion, palliative care, acute pain management, and obstetrics. It is also a manufacturer of specialist pneumatic oxygen-powered life support ventilators.
- Revenue in GBP (TTM)37.63m
- Net income in GBP-6.03m
- Incorporated1998
- Employees224.00
- LocationInspiration Healthcare Group PLC2 Satellite Business VillageCRAWLEY RH10 9NEUnited KingdomGBR
- Phone+44 170 976 1000
- Fax+44 170 976 1066
- Websitehttps://www.inspiration-healthcare.com/
Mergers & acquisitions
| Acquired company | IHC:LSE since announced | Transaction value |
|---|---|---|
| Airon Corp | -46.25% | 2.50m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genedrive PLC | 272.00k | -5.00m | 10.46m | 43.00 | -- | 1.96 | -- | 38.44 | -0.0407 | -0.0407 | 0.0022 | 0.0098 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
| Genincode PLC | 2.16m | -7.02m | 11.95m | 36.00 | -- | 5.02 | -- | 5.53 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
| Ondine Biomedical Inc | 667.95k | -8.00m | 15.57m | 43.00 | -- | 11.00 | -- | 23.30 | -0.0407 | -0.0407 | 0.0034 | 0.0051 | 0.1079 | 0.4237 | 4.74 | -- | -129.24 | -- | -193.37 | -- | 58.44 | -- | -1,198.01 | -- | 1.06 | -- | 0.206 | -- | 88.56 | -- | 25.60 | -- | -- | -- |
| Renalytix PLC | 2.56m | -34.80m | 15.76m | 80.00 | -- | 0.6413 | -- | 6.15 | -0.4259 | -0.4259 | 0.0312 | 0.1481 | 0.0646 | 2.88 | 4.06 | 32,021.80 | -87.73 | -58.25 | -120.00 | -67.03 | 20.60 | -- | -1,358.30 | -1,904.79 | 1.71 | -9.62 | 0.397 | -- | 14.58 | -- | 18.52 | -- | -- | -- |
| Verici DX PLC | 3.26m | -3.62m | 16.37m | 19.00 | -- | 2.21 | -- | 5.02 | -0.0199 | -0.0199 | 0.0166 | 0.0306 | 0.4038 | -- | 5.71 | 232,988.50 | -44.82 | -- | -58.12 | -- | 77.06 | -- | -110.99 | -- | -- | -- | 0.0183 | -- | -- | -- | 23.43 | -- | -- | -- |
| Abingdon Health PLC | 5.34m | -2.24m | 18.01m | 82.00 | -- | 6.24 | -- | 3.37 | -0.0184 | -0.0184 | 0.0439 | 0.0149 | 0.8978 | 7.67 | 4.74 | 65,170.73 | -37.55 | -51.31 | -58.04 | -79.85 | 57.35 | 33.16 | -41.82 | -139.64 | 1.59 | -- | 0.3572 | -- | 42.68 | -- | 83.77 | -- | -- | -- |
| Polarean Imaging PLC | 1.41m | -6.43m | 19.01m | 29.00 | -- | 1.60 | -- | 13.52 | -0.0242 | -0.0242 | 0.0053 | 0.0099 | 0.1075 | 0.5109 | 1.84 | 48,502.78 | -49.18 | -61.45 | -58.32 | -69.17 | 44.78 | 50.68 | -457.39 | -810.92 | 5.24 | -- | 0.0093 | -- | -13.75 | -18.24 | 14.53 | -- | 64.51 | -- |
| Inspiration Healthcare Group PLC | 37.63m | -6.03m | 19.28m | 224.00 | -- | 0.5064 | -- | 0.5123 | -0.0883 | -0.0883 | 0.5516 | 0.4245 | 0.7243 | 1.67 | 3.87 | 167,991.10 | -11.61 | 1.04 | -14.18 | 1.28 | 47.53 | 47.61 | -16.04 | 1.16 | 0.9698 | -0.534 | 0.307 | -- | -8.74 | 19.43 | -2,318.38 | -- | 32.41 | -- |
| Belluscura PLC | 621.36k | -13.94m | 20.10m | 35.00 | -- | 1.23 | -- | 32.35 | -0.1056 | -0.1056 | 0.0048 | 0.0968 | 0.0372 | 0.3042 | 0.1975 | 17,753.15 | -83.37 | -49.84 | -96.68 | -54.78 | -116.54 | -66.07 | -2,243.45 | -1,277.34 | 1.71 | -3.43 | 0.00 | -- | -40.96 | 27.44 | -127.13 | -- | 41.32 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BGF Investment Management Ltd.as of 23 Jul 2024 | 18.87m | 21.04% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Aug 2023 | 5.94m | 6.63% |
| Liontrust Investment Partners LLPas of 30 Jun 2024 | 4.20m | 4.68% |
| Octopus Investments Ltd.as of 30 Jun 2024 | 3.80m | 4.24% |
| Castlefield Investment Partners LLPas of 30 Jun 2024 | 2.32m | 2.59% |
| BlackRock Investment Management (UK) Ltd.as of 01 Aug 2024 | 2.18m | 2.43% |
| Progressive Asset Management Ltd.as of 01 Aug 2024 | 1.58m | 1.76% |
| Premier Fund Managers Ltd.as of 31 May 2024 | 883.03k | 0.99% |
| Hargreaves Lansdown Asset Management Ltd.as of 01 Aug 2024 | 668.00k | 0.75% |
| HSBC Global Asset Management (UK) Ltd.as of 01 Aug 2024 | 356.00k | 0.40% |
